healthcare · prescription drug pricing
Trump Extends Most Favored Nation Drug Pricing to Every Medicaid Program in America
Published · Updated
Cited: AP News, The White House (.gov), The New York Times
TL;DR
President Trump extends Most Favored Nation drug pricing to all Medicaid programs, projecting $65 billion in savings over the next decade.
Why now
Drug prices have dropped the most in over 60 years, and this policy expansion aims to lock in those savings for all Medicaid beneficiaries.
Agree / conflict
Supporters praise the move as historic relief, while critics worry about long-term impacts on pharmaceutical innovation.
Takeaway
Medicaid and Medicare beneficiaries will see significant reductions in drug costs, with potential broader economic benefits.
President Trump has announced that all 50 states, the District of Columbia, and Puerto Rico will adopt Most Favored Nation (MFN) drug pricing for their Medicaid programs. This expansion is projected to save nearly $65 billion over the next decade, building on the sharpest annual drop in prescription drug prices in over 60 years. The administration reports that 26 of the world's largest drugmakers, covering 90% of branded U.S. drugs, have agreed to these terms, with GLP-1 drugs now starting at $149 per month and Medicare seniors paying as low as $50.
The move is part of a broader effort to reduce healthcare costs and bring drug manufacturing back to the U.S. While the immediate impact is lower out-of-pocket costs for millions of Americans, experts are watching how this will affect drug innovation and availability in the long run. For now, the policy represents a significant shift in how the U.S. negotiates drug prices, with potential ripple effects across the entire healthcare system.
FAQ
What is Most Favored Nation (MFN) drug pricing?
MFN pricing ensures that U.S. drug prices are set to match the lowest prices negotiated by other developed countries, preventing Americans from paying more for the same medications.
How much will this save Medicaid programs?
The expansion is projected to save Medicaid programs nearly $65 billion over the next decade.
Which states are participating?
All 50 states, the District of Columbia, and Puerto Rico are participating in the MFN drug pricing model.
What are the expected savings for seniors?
Medicare seniors will see significant savings, with GLP-1 drugs dropping to as low as $50 per month, and over 500,000 seniors have already saved $216 million.
When did this policy take effect?
The policy was announced on September 18, 2026, and is already being implemented across all Medicaid programs.
Sources
Canonical URL: /trend/2026/trump-extends-most-favored-nation-drug-pricing-to-every-medicaid-program-in-amer
Disclaimer
Digests summarize public sources. They are not advice, forecasts, or a complete record of every trend.
This digest was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.
All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.
This digest may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.
Always do your own research (DYOR) before making any decisions based on the information presented.